Start Assessment
Takes 2-3 minutes
Clinical Integration Roadmap
Zenith is actively developing a clinical integration pathway with registered Australian practitioners. This page outlines our planned approach to medically supervised peptide protocols.
Note: Clinical pathway integration is currently in development. Subscribe for updates on practitioner availability.
Why a Structured Model Matters
Peptide therapies require medical oversight. Without appropriate screening and prescribing, patients are exposed to unnecessary medical and legal risk. Zenith operates within a practitioner-led framework designed to prioritise safety, quality and long-term legitimacy.
- Telehealth screening protects patient and brand integrity
- Prescription model removes criminal and regulatory exposure
- Australian-registered prescribers provide defensible oversight
- Independent laboratory testing and COAs build trust
- Clear protocol documentation reduces misuse
How It Works
A clear, structured pathway from assessment to ongoing support.
Assessment
Complete targeted questions about your goals, health history and lifestyle.
Protocol Match
Your profile will be matched to a structured peptide protocol.
Practitioner Review
Future: Suitability reviewed by Australian-registered practitioner.
Protocol Confirmation
Future: Individualised protocol confirmed where clinically appropriate.
Delivery
Precision delivery system dispatched with cold-chain handling.
Future Monitoring
Planned: Follow-up support and structured protocol review.
Quality & Safety Standards
Example Pathway
Jordan
Fat Loss Protocol
How the System Works
A structured flow from you to your personalised protocol.
Enhance Your Protocol Matching
For more precise protocol recommendations, you can optionally upload recent blood test results.
Designed for Long-Term Legitimacy
Zenith does not operate in regulatory grey zones. All protocols are delivered within Australian regulatory frameworks and practitioner oversight models. This structure protects patients, practitioners, payment providers and platform longevity.
Common Questions
No. Where regulated, peptides require practitioner assessment and prescription.
No. Suitability is determined by the prescriber following medical screening.
Yes. Independent laboratory testing and batch traceability form part of our quality assurance framework.
No. Zenith operates within structured regulatory pathways and practitioner oversight.
If deemed unsuitable, no prescription will be issued.
Launching Soon
Our regulated telehealth pathway is currently in development. Register below for priority access.
All peptide protocols are provided subject to medical suitability and prescription by Australian-registered practitioners where required. Information on this website is for educational purposes only and does not constitute medical advice. Prescribing decisions are made at the sole discretion of the practitioner. No therapeutic claims are made.